Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine whether implantation of a multifocal IOL with a modified addition at lens plane(Restor +3) results in better intermediate visual acuity with similar performance at distance and near compared to other multifocal IOL with similar design but with higher addition at lens plane. Patient's contrast sensitivity of vision and best reading distance following Restor +3 implantation were also assessed.
Study hypothesis: the implantation of an intraocular lens (IOL) with a modified addition at lens plane (restor +3, Alcon Laboratories,Inc) results in better intermediate visual acuity with similar distance and near visual acuity after cataract surgery.
| Condition | Intervention |
|---|---|
|
To Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual Acuity |
Other: Implantation of a multifocal Intraocular lens |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
- distance,intermediate and near visual acuity [ Time Frame: 1, 3 and 6 months ] [ Designated as safety issue: Yes ]
- reading speed and contrast sensitivity [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 32 |
| Study Start Date: | December 2009 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Restor +3
patients will be implanted bilaterally with Restor + 3
|
Other: Implantation of a multifocal Intraocular lens
Bilateral implantation of a multifocal IOl
Other Names:
|
|
restor +4
Patients will be implanted bilaterally with Restor +4
|
Other: Implantation of a multifocal Intraocular lens
Bilateral implantation of a multifocal IOl
Other Names:
|
Detailed Description:
Patients with bilateral visually significant cataract with corneal astigmatism lower than 1.0D (diopters) will be eligible for inclusion in the study. Exclusion criteria will be any ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination), or incomplete follow-up.
Patients will be examined before surgery and at 1, 7, 30, 90 days and 3and 6 months after surgery.
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
The sutdy population will be patients implanted bilaterally with the selected multifocal IOL
Inclusion Criteria:
- •Patients with bilateral visually significant cataract with corneal astigmatism lower than 1.0D (diopters)
Exclusion Criteria:
- Ocular diseases, such as corneal opacities or irregularity, dry eye amblyopia, anisometropia, glaucoma, retinal abnormalities
- Surgical complications
- Intraocular lens (IOL) tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination)
- Incomplete follow-up.
Contacts and Locations
More Information
Publications:
| Responsible Party: | Marcony R Santhiago, University of São Paulo |
| ClinicalTrials.gov Identifier: | NCT01027533 History of Changes |
| Other Study ID Numbers: | MRS.1703 |
| Study First Received: | December 7, 2009 |
| Last Updated: | July 1, 2010 |
| Health Authority: | Brazil: Ethics Committee |
Keywords provided by University of Sao Paulo:
|
multifocal intraocular lens visual acuity presbiopia |
ClinicalTrials.gov processed this record on May 19, 2013